Corrigendum | Open Access
Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
Received18 Sept 2016
Accepted26 Sept 2016
Published21 Nov 2016
In the article titled “HDR Brachytherapy in the Management of High-Risk Prostate Cancer” , there was an error in Table 2, which should be corrected as follows: For Hoskin et al. , the dose should read 35.75 Gy in 13 fractions EBRT, not 55 Gy in 20 fractions EBRT.
S. Masson, R. Persad, and A. Bahl, “HDR brachytherapy in the management of high-risk prostate cancer,” Advances in Urology, vol. 2012, Article ID 980841, 6 pages, 2012.View at: Publisher Site | Google Scholar
Copyright © 2016 Susan Masson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.